154 related articles for article (PubMed ID: 16182364)
21. Increased expression of cyclin A1 protein is associated with all-trans retinoic acid-induced apoptosis.
Ekberg J; Brunhoff C; Järås M; Fan X; Landberg G; Persson JL
Int J Biochem Cell Biol; 2006; 38(8):1330-9. PubMed ID: 16517207
[TBL] [Abstract][Full Text] [Related]
22. Development-dependent expression of cyclin D3 in precursor T-cell lymphoblastic leukemia/lymphoma.
Sasaki E; Yatabe Y; Hashimoto M; Yamashita Y; Hasegawa Y; Kojima H; Nagasawa T; Mori N
Pathol Int; 2007 Feb; 57(2):53-9. PubMed ID: 17300668
[TBL] [Abstract][Full Text] [Related]
23. [Flt-3/ITD mutation in pediatric leukemia and its clinical significance].
Wang J; Wang T; Li S; Lin L; Gang Y
Ai Zheng; 2007 Jan; 26(1):58-63. PubMed ID: 17222369
[TBL] [Abstract][Full Text] [Related]
24. Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantation.
Yang DH; Lee JJ; Mun YC; Shin HJ; Kim YK; Cho SH; Chung IJ; Seong CM; Kim HJ
Am J Hematol; 2007 Jan; 82(1):1-5. PubMed ID: 16986129
[TBL] [Abstract][Full Text] [Related]
25. High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNS.
Cario G; Izraeli S; Teichert A; Rhein P; Skokowa J; Möricke A; Zimmermann M; Schrauder A; Karawajew L; Ludwig WD; Welte K; Schünemann HJ; Schlegelberger B; Schrappe M; Stanulla M
J Clin Oncol; 2007 Oct; 25(30):4813-20. PubMed ID: 17947730
[TBL] [Abstract][Full Text] [Related]
26. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
27. PLK1 expression and BI 2536 effects in childhood acute lymphoblastic leukemia.
Oliveira JC; Pezuk JA; Brassesco MS; Morales AG; Queiroz RG; Scrideli CA; Tone LG
Pediatr Blood Cancer; 2014 Jul; 61(7):1227-31. PubMed ID: 24519995
[TBL] [Abstract][Full Text] [Related]
28. Mutant p53 and cyclin A1 protein expression in primary laryngeal squamous cell carcinomas do not correlate to second primary tumours of the head and neck.
Farhadieh RD; Smee R; Rees CG; Salardini A; Eggleton S; Yang JL; Russell PJ
ANZ J Surg; 2009; 79(1-2):48-54. PubMed ID: 19183379
[TBL] [Abstract][Full Text] [Related]
29. Reassessment of the prognostic significance of hypodiploidy in pediatric patients with acute lymphoblastic leukemia.
Raimondi SC; Zhou Y; Mathew S; Shurtleff SA; Sandlund JT; Rivera GK; Behm FG; Pui CH
Cancer; 2003 Dec; 98(12):2715-22. PubMed ID: 14669294
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.
Bader P; Kreyenberg H; Henze GH; Eckert C; Reising M; Willasch A; Barth A; Borkhardt A; Peters C; Handgretinger R; Sykora KW; Holter W; Kabisch H; Klingebiel T; von Stackelberg A;
J Clin Oncol; 2009 Jan; 27(3):377-84. PubMed ID: 19064980
[TBL] [Abstract][Full Text] [Related]
31. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
[TBL] [Abstract][Full Text] [Related]
32. Validation by RQ-PCR and flow cytometry of alpha-defensin1-3 (DEFA1-3) overexpression in relapsed and refractory acute lymphoblastic leukemia.
Te Kronnie G; Bicciato S; Franceschini L; Accordi B; Dellíorto MC; Rinaldi A; Pession A; Barisone E; Conter V; Locatelli F; Basso G
Oncol Rep; 2006 Feb; 15(2):341-6. PubMed ID: 16391852
[TBL] [Abstract][Full Text] [Related]
33. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig WD; Riehm H; Schrappe M
Klin Padiatr; 2005; 217(6):310-20. PubMed ID: 16307416
[TBL] [Abstract][Full Text] [Related]
34. Monitoring minimal residual disease with flow cytometry, antigen-receptor gene rearrangements and fusion transcript quantification in Philadelphia-positive childhood acute lymphoblastic leukemia.
Thörn I; Botling J; Hermansson M; Lönnerholm G; Sundström C; Rosenquist R; Barbany G
Leuk Res; 2009 Aug; 33(8):1047-54. PubMed ID: 19157547
[TBL] [Abstract][Full Text] [Related]
35. Expression of Fas ligand in newly diagnosed childhood acute lymphoblastic leukemia.
Volm M; Zintl F; Sauerbrey A; Koomägi R
Anticancer Res; 1999; 19(4C):3399-402. PubMed ID: 10629626
[TBL] [Abstract][Full Text] [Related]
36. DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia.
Agrawal S; Unterberg M; Koschmieder S; zur Stadt U; Brunnberg U; Verbeek W; Büchner T; Berdel WE; Serve H; Müller-Tidow C
Cancer Res; 2007 Feb; 67(3):1370-7. PubMed ID: 17283175
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of WT1 gene expression in pediatric acute myeloid leukemia.
Rodrigues PC; Oliveira SN; Viana MB; Matsuda EI; Nowill AE; Brandalise SR; Yunes JA
Pediatr Blood Cancer; 2007 Aug; 49(2):133-8. PubMed ID: 16883592
[TBL] [Abstract][Full Text] [Related]
38. [Correlation between karyotypic characteristics and treatment outcome in childhood acute lymphoblastic leukemia].
Tie LJ; Gu LJ; Chen J; Dong L; Chen J; Pan C; Ye H; Xue HL; Tang JY; Wang YP
Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):339-43. PubMed ID: 16875587
[TBL] [Abstract][Full Text] [Related]
39. [Cell surface markers and treatment results in childhood acute lymphoblastic leukemia (ALL)].
Koizumi S; Tsurusawa M; Katano N
Rinsho Ketsueki; 1997 May; 38(5):389-92. PubMed ID: 9194381
[No Abstract] [Full Text] [Related]
40. Correlation of telomerase activity to apoptosis and survival in adult acute lymphoblastic leukemia: an Egyptian single-center study.
Asfour IA; Fayek MH; El-Kourashy SA; Youssef SR; El-Gohary GM; Mohamed OF
Ann Hematol; 2008 Mar; 87(3):213-21. PubMed ID: 18175116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
